Table of Contents
Hepatitis Research and Treatment
Volume 2011, Article ID 695859, 4 pages
http://dx.doi.org/10.1155/2011/695859
Research Article

Expression of Hepatitis B Virus Surface Antigen Containing Y100C Variant Frequently Detected in Occult HBV Infection

1Laboratory of Molecular Virology, Oswaldo Cruz Institute, FIOCRUZ, Avenida Brasil 4365, 21045-900 Rio de Janeiro, RJ, Brazil
2INSERM U871, 151 Cours Albert Thomas, 69424 Lyon, France

Received 22 November 2010; Accepted 4 January 2011

Academic Editor: William Irving

Copyright © 2011 Francisco C. A. Mello et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. W. Shepard, E. P. Simard, L. Finelli, A. E. Fiore, and B. P. Bell, “Hepatitis B virus infection: epidemiology and vaccination,” Epidemiologic Reviews, vol. 28, no. 1, pp. 112–125, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. V. Carreño, J. Bartolomé, I. Castillo, and J. A. Quiroga, “Occult hepatitis B virus and hepatitis C virus infections,” Reviews in Medical Virology, vol. 18, no. 3, pp. 139–157, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. S. A. Gomes, C. F. T. Yoshida, and C. Niel, “Detection of hepatitis B virus DNA in hepatitis B surface antigen-negative serum by polymerase chain reaction: evaluation of different primer pairs and conditions,” Acta Virologica, vol. 40, no. 3, pp. 133–138, 1996. View at Google Scholar · View at Scopus
  4. D. Jeantet, I. Chemin, B. Mandrand, F. Zoulim, C. Trepo, and A. Kay, “Characterization of two hepatitis B virus populations isolated from a hepatitis B surface antigen-negative patient,” Hepatology, vol. 35, no. 5, pp. 1215–1224, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Q. Hu, “Occult hepatitis B virus infection and its clinical implications,” Journal of Viral Hepatitis, vol. 9, no. 4, pp. 243–257, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Raimondo, T. Pollicino, I. Cacciola, and G. Squadrito, “Occult hepatitis B virus infection,” Journal of Hepatology, vol. 46, no. 1, pp. 160–170, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Torbenson and D. L. Thomas, “Occult hepatitis B,” Lancet Infectious Diseases, vol. 2, no. 8, pp. 479–486, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Y. Chen, C. F. Kao, C. M. Chen et al., “Mechanisms for inhibition of hepatitis B virus gene expression and replication by hepatitis C virus core protein,” Journal of Biological Chemistry, vol. 278, no. 1, pp. 591–607, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. F. B. Hollinger and G. Sood, “Occult hepatitis B virus infection: a covert operation,” Journal of Viral Hepatitis, vol. 17, no. 1, pp. 1–15, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. C. G. Schüttler, N. Fiedler, K. Schmidt, R. Repp, W. H. Gerlich, and S. Schaefer, “Suppression of hepatitis B virus enhancer 1 and 2 by hepatitis C virus core protein,” Journal of Hepatology, vol. 37, no. 6, pp. 855–862, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. V. Chaudhuri, R. Tayal, B. Nayak, S. K. Acharya, and S. K. Panda, “Occult hepatitis B virus infection in chronic liver disease: full-length genome and analysis of mutant surface promoter,” Gastroenterology, vol. 127, no. 5, pp. 1356–1371, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. N. M. Araujo, M. Branco-Vieira, A. C. M. Silva et al., “Occult hepatitis B virus infection in HIV-infected patients: evaluation of biochemical, virological and molecular parameters,” Hepatology Research, vol. 38, no. 12, pp. 1194–1203, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Jeantet, I. Chemin, B. Mandrand et al., “Cloning and expression of surface antigens from occult chronic hepatitis B virus infections and their recognition by commercial detection assays,” Journal of Medical Virology, vol. 73, no. 4, pp. 508–515, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Kreutz, “Molecular, immunological and clinical properties of mutated hepatitis B viruses,” Journal of Cellular and Molecular Medicine, vol. 6, no. 1, pp. 113–143, 2002. View at Google Scholar · View at Scopus
  15. K. M. Weinberger, T. Bauer, S. Böhm, and W. Jilg, “High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum,” Journal of General Virology, vol. 81, no. 5, pp. 1165–1174, 2000. View at Google Scholar · View at Scopus
  16. K. Yamamoto, M. Horikita, F. Tsuda et al., “Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen,” Journal of Virology, vol. 68, no. 4, pp. 2671–2676, 1994. View at Google Scholar · View at Scopus
  17. C. Gutiérrez, M. Devesa, C. L. Loureiro, G. León, F. Liprandi, and F. H. Pujol, “Molecular and serological evaluation of surface antigen negative hepatitis B virus infection in blood donors from Venezuela,” Journal of Medical Virology, vol. 73, no. 2, pp. 200–207, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. H. L. Zaaijer, P. Torres, A. Ontañón et al., “Multiple surface antigen mutations in five blood donors with occult hepatitis B virus infection,” Journal of Medical Virology, vol. 80, no. 8, pp. 1344–1349, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. J. S. Motta, F. C. Mello, B. V. Lago, R. M. Perez, S. A. Gomes, and F. F. Figueiredo, “Occult hepatitis B virus infection and lamivudine-resistant mutations in isolates from renal patients undergoing hemodialysis,” Journal of Gastroenterology and Hepatology, vol. 25, no. 1, pp. 101–106, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. A. R. C. Motta-Castro, R. M. B. Martins, N. M. Araujo et al., “Molecular epidemiology of hepatitis B virus in an isolated Afro-Brazilian community,” Archives of Virology, vol. 153, no. 12, pp. 2197–2205, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. M. L. Cuestas, C. W. Rivero, M. L. Minassian et al., “Naturally occurring hepatitis B virus (HBV) variants with primary resistance to antiviral therapy and S-mutants with potential primary resistance to adefovir in Argentina,” Antiviral Research, vol. 87, no. 1, pp. 74–77, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Niel, M. T. B. Moraes, A. M. C. Gaspar, R. F. T. Yoshida, and S. A. Gomes, “Genetic diversity of hepatitis B virus strains isolated in Rio de Janeiro, Brazil,” Journal of Medical Virology, vol. 44, no. 2, pp. 180–186, 1994. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Kumar, K. Tamura, and M. Nei, “MEGA: molecular evolutionary genetics analysis software for microcomputers,” Computer Applications in the Biosciences, vol. 10, no. 2, pp. 189–191, 1994. View at Google Scholar · View at Scopus
  24. P. F. Coleman, Y. C. J. Chen, and I. K. Mushahwar, “Immunoassay detection of hepatitis B surface antigen mutants,” Journal of Medical Virology, vol. 59, no. 1, pp. 19–24, 1999. View at Publisher · View at Google Scholar · View at Scopus
  25. M. P. Cooreman, M. H. Van Roosmalen, R. Te Morsche et al., “Characterization of the reactivity pattern of murine monoclonal antibodies against wild-type hepatitis B surface antigen to G145R and other naturally occurring 'a' loop escape mutations,” Hepatology, vol. 30, no. 5, pp. 1287–1292, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. J. H. Ireland, B. O'Donnell, A. A. Basuni et al., “Reactivity of 13 in vitro expressed hepatitis B surface antigen variants in 7 commercial diagnostic assays,” Hepatology, vol. 31, no. 5, pp. 1176–1182, 2000. View at Google Scholar · View at Scopus
  27. C. Jolivet-Reynaud, M. Lsenchal, B. O'Donnell et al., “Localization of hepatitis B surface antigen epitopes present on variants and specifically recognised by anti-hepatitis B surface antigen monoclonal antibodies,” Journal of Medical Virology, vol. 65, no. 2, pp. 241–249, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. A. J. Zuckerman and J. N. Zuckerman, “Molecular epidemiology of hepatitis B virus mutants,” Journal of Medical Virology, vol. 58, no. 3, pp. 193–195, 1999. View at Google Scholar · View at Scopus
  29. W. F. Carman, J. Korula, L. Wallace, R. MacPhee, L. Mimms, and R. Decker, “Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA,” Lancet, vol. 345, no. 8962, pp. 1406–1407, 1995. View at Google Scholar · View at Scopus
  30. I. Chemin, D. Jeantet, A. Kay, and C. Trépo, “Role of silent hepatitis B virus in chronic hepatitis B surface antigen(-) liver disease,” Antiviral Research, vol. 52, no. 2, pp. 117–123, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Sengupta, S. Rehman, H. Durgapal, S. K. Acharya, and S. K. Panda, “Role of surface promoter mutations in hepatitis B surface antigen production and secretion in occult hepatitis B virus infection,” Journal of Medical Virology, vol. 79, no. 3, pp. 220–228, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. J. S. Bonifacino, P. Cosson, N. Shah, and R. D. Klausner, “Role of potentially charged transmembrane residues in targeting proteins for retention and degradation within the endoplasmic reticulum,” EMBO Journal, vol. 10, no. 10, pp. 2783–2794, 1991. View at Google Scholar · View at Scopus
  33. K. Sato, M. Sato, and A. Nakano, “Rer1p, a retrieval receptor for ER membrane proteins, recognizes transmembrane domains in multiple modes,” Molecular Biology of the Cell, vol. 14, no. 9, pp. 3605–3616, 2003. View at Publisher · View at Google Scholar · View at Scopus